Skip to main content

Table 4 Comparison of variables between patients who were newly classified as Behçet’s disease according to ICBD classification criteria

From: Birmingham Behçet’s service: classification of disease and application of the 2014 International Criteria for Behçet’s Disease (ICBD) to a UK cohort

Variables

Patients reclassified as BD (n = 38)

Patients not reclassified as BD (n = 152)

P-valuea

Characteristics

 Age (years)

 Sex, male (n %))

45.0 ± 13.9

16 (42.1)

40.8 ± 13.5

56 (36.8)

 

Clinical manifestations (n (%)

 Oral aphthosis

 Genital aphthosis

 Pseudofolliculitis

 Acneiform rash

 Erythema nodosum

 Skin aphthosis

 Anterior uveitis

 Posterior uveitis

 Retinal vasculitis

 Peripheral nervous

 Central nervous

 Arterial thrombosis

 Large vein thrombosis

 Phlebitis

 Superficial phlebitis

 Pathergy test positivity

38 (100)

25 (65.8)

0 (0)

0 (0)

0 (0)

0 (0)

11 (28.9)

8 (21.1)

5 (13.2)

1 (2.6)

10 (26.3)

(7.9)

(10.5)

1 (2.6)

1 (2.6)

0 (0)

149 (98.0)

136 (89.5)

41 (27.0)

42 (27.6)

49 (32.2)

7 (4.6)

72 (47.4)

46 (30.3)

28 (18.4)

2 (1.3)

8 (5.3)

5 (3.3)

17 (11.2)

4 (2.6)

4 (2.6)

23 (15.1)

1.000

<0.001

<0.001

<0.001

<0.001

0.348

0.045

0.318

0.632

0.490

<0.001

0.199

1.000

1.000

1.000

0.005

  1. aUsing Fisher’s exact test